CLEAR CELL ADENOCARCINOMA
Clinical trials for CLEAR CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo shows promise for rare, Tough-to-Treat ovarian cancer
Disease control OngoingThis study tests whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) works better than nivolumab alone for people with advanced clear cell ovarian, fallopian tube, or peritoneal cancer. About 46 participants will receive either one or both drugs to see if …
Matched conditions: CLEAR CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated May 17, 2026 02:24 UTC
-
New hope for recurrent ovarian cancer: drug combo extends life?
Disease control OngoingThis study looked at whether adding the drug bevacizumab to standard chemotherapy after surgery helps people with ovarian, peritoneal, or fallopian tube cancer that has come back live longer. Over 1,000 participants were randomly assigned to receive chemo alone or chemo plus beva…
Matched conditions: CLEAR CELL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC